Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 45.77B P/E 35.67 EPS this Y -11.60% Ern Qtrly Grth -9.40%
Income 1.66B Forward P/E 18.97 EPS next Y 8.80% 50D Avg Chg -6.00%
Sales 15.44B PEG 13.79 EPS past 5Y - 200D Avg Chg -7.00%
Dividend N/A Price/Book 2.26 EPS next 5Y 1.21% 52W High Chg -14.00%
Recommedations 2.60 Quick Ratio 0.63 Shares Outstanding 1.91B 52W Low Chg 6.00%
Insider Own 0.02% ROA 6.67% Shares Float 1.73B Beta -
Inst Own 99.27% ROE 10.67% Shares Shorted/Prior 36.03M/27.45M Price 23.90
Gross Margin 55.96% Profit Margin 10.77% Avg. Volume 6,846,304 Target Price 22.09
Oper. Margin 16.12% Earnings Date - Volume 15,999,131 Change 1.06%
About Kenvue Inc.

Kenvue Inc. operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands. The Skin Health and Beauty segment provides face and body care, hair, sun, and other care products under the Neutrogena, Aveeno, Dr.Ci:Labo, Le Petit Marseillais, Lubriderm, Rogaine, and OGX brand names. The Essential Health segment offers oral and baby, women's health, wound, and other care products under the Listerine, Johnson's, Band-Aid, and Stayfree, o.b., tampons, Carefree, and Desitin Diaper Rash brands. The company was incorporated in 2022 and is headquartered in Skillman, New Jersey.

Kenvue Inc. News
04/25/24 Kenvue Declares Quarterly Cash Dividend
04/24/24 Will Weakness in Kenvue Inc.'s (NYSE:KVUE) Stock Prove Temporary Given Strong Fundamentals?
04/16/24 J&J CFO: We've 'beefed up' cardiovascular medical devices in hopes of reviving our medtech business
04/08/24 Kenvue Revamps Cyber Tools After Spinoff From J&J
04/05/24 Kenvue to Announce First Quarter 2024 Results on May 7, 2024
03/12/24 7 High-Quality Blue-Chip Stocks to Buy if You’re Looking for Stability
03/07/24 Kenvue to Showcase 22 New Sets of Clinical Data at American Academy of Dermatology Association Meeting
03/05/24 Heard on the Street: Does Bayer Have the Formula to Avoid a Breakup?
02/13/24 Kenvue to Present at the Consumer Analyst Group of New York Conference on February 23, 2024
02/09/24 Kenvue Full Year 2023 Earnings: EPS Misses Expectations
02/08/24 Harley-Davidson, Philip Morris, Kenvue: Trending tickers
02/08/24 Kenvue Inc (KVUE) Reports Mixed Full Year and Q4 Earnings Amidst Market Headwinds
02/08/24 Kenvue Reports Full Year and Fourth Quarter 2023 Results
01/10/24 3 Unshakeable Dividend Stocks for Lifelong Wealth
01/05/24 Kenvue to Announce Fourth Quarter and Full Year 2023 Results on February 8, 2024
12/20/23 How To Earn $1,000 Per Month From Kenvue (NYSE: KVUE) Stock
12/19/23 Accenture, AIG, Kenvue: Trending Tickers
12/06/23 How To Earn $500 Per Month From (NYSE: KVUE) Kenvue Inc.'s Stock
12/01/23 Wealth From Wellness: 7 Healthcare Stocks to Inoculate Your Portfolio
11/30/23 Fresh on the Market: 3 Top Picks From the Renaissance IPO ETF
KVUE Chatroom

User Image Zcgjniy653 Posted - 1 day ago

$KVUE Analyst price target for next week. live-trade-ideas.winning-trading-room.xyz

User Image TylerBlaxcell84 Posted - 1 day ago

$KVUE Analyst price target for next week. live-trade-ideas.winning-trading-room.xyz

User Image milhouser69 Posted - 1 day ago

$KVUE doing some DD on this, what is the public consensus on this for earnings?

User Image TylerArchibald48 Posted - 2 days ago

$KVUE Analyst price target for today. live-trade-ideas.winning-trading-room.xyz

User Image TeresaTrades Posted - 3 days ago

Largest PUT OI increases $TSLA $KVUE $BKR $JBLU $AAPL

User Image Kgzfign752 Posted - 3 days ago

$kvue Analyst price target for today. stock-trading-group-discord.winning-trading-room.xyz

User Image CharismaticLeo Posted - 3 days ago

This guy is back and better than ever with his alerts🔥make sure you give him a follow! $CCL $ITUB $JBLU $KVUE - Next up?

User Image Stocksrunner Posted - 3 days ago

$KVUE Kenvue witnessed a staggering 86.91% decline in its short percent of float since the last report. This massive drop signals a potential shift in sentiment among short sellers, likely indicating reduced bearish bets or significant short-covering activity. https://stocksrunner.com/symbol/KVUE

User Image Awbscene Posted - 6 days ago

$KVUE Great divi stock

User Image ProTraderColin Posted - 1 week ago

$KVUE a suit really doesn’t want this over 19.52. 7th attempt to break that hod

User Image ProTraderColin Posted - 1 week ago

$KVUE going for big daily resistance break again 19.50

User Image Vitalyzed10 Posted - 1 week ago

$KVUE

User Image ProTraderColin Posted - 1 week ago

$PFE $KVUE not sure which company is worse

User Image TeresaTrades Posted - 1 week ago

Largest PUT OI decreases $CCJ $TSLA $KVUE $AVTR $VALE

User Image UndertakerExplains Posted - 1 week ago

@i3desiderata @Baddb they won’t get away with it. They have already offered 9 billion to settle the cases. They already have paid 700m to settle with 42 states attorney generals. There’s nothing to get away with it. They have already said their goal is to resolve the claims. There is bipartisan support in both houses of Congress to get JNJ to resolve these claims fairly. There is also a DOJ investigation (where no follow up has been given in many years despite Senators asking). Both their bankruptcies have been dismissed including one by a Court a notch below SCOTUS. Supreme Court Justice ACB even mentioned JNJ and their bankruptcy tactics during the Purdue Pharma oral arguments. Plus SCOTUS already upheld a 2.2b judgment against JNJ for talc. Also, the spin out of $KVUE only covers US and Canada liabilities. $JNJ is still on the hook for the rest of the world talc that they sold. Saying you think they will get away with it flies in the face of all facts and is divorced from reality.

User Image Vitalyzed10 Posted - 1 week ago

$KVUE

User Image TeresaTrades Posted - 1 week ago

Largest PUT OI increases $VFC $MPW $AAL $KVUE $PLTR

User Image TheStockProd Posted - 1 week ago

@Inamar06 @Wigglyick I do believe the recall in Africa could affect the price negatively. This could be an interesting dip buy opportunity if it goes along the strategy you have in mind. Best of luck to ya

User Image TheStockProd Posted - 1 week ago

$KVUE What do you guys think about this recall in Africa?

User Image TonyG6xxx Posted - 2 weeks ago

$PFE $KVUE $NKE a few stocks I've been bag holding for a little while. Not selling them now, but they have been complete trash all year.

User Image theviolator Posted - 2 weeks ago

$KVUE

User Image Doorkey Posted - 2 weeks ago

$KVUE My hopes are $22 before next divvy. Buyer at 18$ in retirement accts.

User Image Inamar06 Posted - 2 weeks ago

$KVUE @Wigglyick Hi. I would like to get your opinion. It’s a spin off. Seems like they have very good brands and it pays a dividend. The selling that I normally see with new spinoffs seems to be stabilizing I was thinking of getting in.

User Image Thestocktraderhubzee Posted - 2 weeks ago

$KVUE Kenvue shares are trading lower after Bernstein initiated coverage on the stock with an Underperform rating and a price target of $18.

User Image InvestorPlace Posted - 2 weeks ago

Kenvue Layoffs 2024: What to Know About the Latest Neutrogena Job Cuts $KVUE https://investorplace.com/2024/04/kenvue-layoffs-2024-what-to-know-about-the-latest-neutrogena-job-cuts/

User Image briefingcom Posted - 3 weeks ago

$JNJ: Johnson & Johnson is making another splash in the M&A space, announcing that it's acquiring ShockWave Medical $SWAV in a deal valued at approximately $13 bln. The purchase price of $335/share in cash represents just a 4.7% premium over yesterday's closing price, but that's because shares of SWAV were already pricing in an acquisition. Recall that on March 26, the Wall Street Journal reported that JNJ was considering an acquisition of SWAV for $11 bln. Using SWAV's stock price from March 25, the $335/share offer equates to a premium of about 17%. After spinning off its consumer business, Kenvue $KVUE, in August 2023, JNJ is left with two main operating segments. https://www.briefing.com/story-stocks/archive/2024/4/5/johnson--and--johnson-bolsters-medtech-segment-again-with-another-sizable-acquisition-(jnj)?utm_campaign=storystocks&utm_medium=social&utm_source=st&utm_content=link

User Image AstroZombie78 Posted - 3 weeks ago

@blueWelder78 they already did a spin-off - $KVUE

User Image Stock_Titan Posted - 3 weeks ago

$KVUE Kenvue to Announce First Quarter 2024 Results on May 7, 2024 https://www.stocktitan.net/news/KVUE/kenvue-to-announce-first-quarter-2024-results-on-may-7-plos4rx5yrne.html

User Image Doorkey Posted - 3 weeks ago

$KVUE Sum crazy (Smart) money being thrown at this. https://whalewisdom.com/stock/kvue

User Image MrMillions19047 Posted - 3 weeks ago

$SOLV $KVUE $HLN $KD $WBD spinoff are barely good, hardly any exceptions. Sad truth.

Analyst Ratings
Bernstein Underperform Apr 11, 24
William Blair Market Perform Apr 3, 24
Goldman Sachs Neutral Mar 4, 24
Goldman Sachs Neutral Mar 1, 24
RBC Capital Outperform Feb 13, 24
JP Morgan Overweight Feb 9, 24
RBC Capital Outperform Feb 9, 24
UBS Neutral Dec 19, 23
Piper Sandler Neutral Nov 17, 23
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
ALLISON RICHARD E JR Director Director Aug 30 Buy 22.9589 5,598 128,524 25,598 08/31/23